NVO - Novo Nordisk A/S

NYSE - NYSE Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

Currency in DKK. All numbers in thousands
Total Revenue18,014,00015,856,00015,710,000
Cost of Revenue2,844,0002,437,0002,356,000
Gross Profit15,171,00013,419,00013,354,000
Operating Expenses
Research Development2,260,0002,066,0001,981,000
Selling General and Administrative5,013,0004,482,0004,176,000
Non Recurring---
Total Operating Expenses---
Operating Income or Loss7,897,0006,870,0007,197,000
Income from Continuing Operations
Total Other Income/Expenses Net201,00013,00012,000
Earnings Before Interest and Taxes8,098,0006,883,0007,210,000
Interest Expense247,000103,000880,000
Income Before Tax7,851,0006,780,0006,330,000
Income Tax Expense1,702,0001,401,0001,255,000
Minority Interest---
Net Income From Continuing Ops6,150,0005,380,0005,074,000
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income6,150,0005,380,0005,074,000
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares6,150,0005,380,0005,074,000